doktorska disertacija
Aleksandar Janev (Author), Mateja Erdani-Kreft (Mentor)

Abstract

Rak sečnega mehurja je deseto najpogostejše rakavo obolenje na svetu. Uporaba humane amnijske membrane (hAM) za zdravljenje raka je ena od perspektivnih idej, ki se je pojavila v zadnjih letih. Cilj doktorske disertacije je bil proučiti celično-biološke mehanizme protirakavega delovanja homogenata in izvlečka hAM na modelih raka in normalnega sečnega mehurja in vitro. Z uporabo različnih molekularnih in mikroskopskih metod smo ugotovili, da pripravka iz hAM zmanjšata izražanje označevalcev fokalnih stikov, migracije, invazije in proliferacije mišično invazivnih urotelijskih celic T24 in neinvazivnih urotelijskih celic papiloma RT4. Dokazali smo, da je eden izmed mehanizmov protirakavega delovanja pripravkov iz hAM inhibicija FAK in p-FAK ter posledično zmanjšanje izražanja genov in proteinov, ki so del signalne poti PI3K/Akt/mTOR v rakavih urotelijskih celicah T24. Poleg tega smo dokazali, da homogenat hAM v mišično invazivnih urotelijskih celicah T24 in urotelijskih celicah papiloma RT4 zavre izražanje proteinov, ki so vpleteni v reorganizacijo aktinskega citoskeleta. Naša raziskava je potrdila, da pripravka iz hAM nimata škodljivega učinka na normalne urotelijske celice. Ugotovili smo, da proučevana pripravka iz hAM delujeta na več molekularnih tarč karcinogeneze, na osnovi česar menimo, da imata potencial za uporabo, kot dodatni protirakavi učinkovini, v večtarčni intravezikalni terapiji po transuretralni resekciji tumorjev sečnega mehurja.

Keywords

human amniotic membrane;normal and cancer urothelial cells;anticancer effect;homogenate;doctoral dissertations;

Data

Language: English
Year of publishing:
Typology: 2.08 - Doctoral Dissertation
Organization: UL BF - Biotechnical Faculty
Publisher: [A. Janev]
UDC: 577.2:616.62-006(043.3)
COBISS: 125956355 Link will open in a new window
Views: 37
Downloads: 17
Average score: 0 (0 votes)
Metadata: JSON JSON-RDF JSON-LD TURTLE N-TRIPLES XML RDFA MICRODATA DC-XML DC-RDF RDF

Other data

Secondary language: Slovenian
Secondary title: ǂThe ǂeffect of human amniotic membrane preparations on the selected signalling pathways of the epithelial-mesenchymal transition of normal and cancer urothelial cells
Secondary abstract: Bladder cancer is the tenth most common cancer. Using human amniotic membrane (hAM) to treat cancer is one of the promising ideas that have emerged in recent years. The aim of the PhD thesis was to investigate the effect of hAM homogenate and extract on different in vitro models of bladder cancer. Using molecular and microscopic methods, we have shown that hAM homogenate and extract reduce the expression of markers of focal adhesion, migration, invasion and proliferation in muscle-invasive urothelial T24 cells and transitional cell papilloma RT4 cells. In addition, we have shown that one of the mechanisms of action is through downregulation of genes and proteins that are part of the FAK/PI3K/Akt/mTOR pathway in T24 cancer cells. We have also shown that the hAM homogenate inhibits the expression of focal adhesion proteins and proteins involved in the reorganization of the actin cytoskeleton of cancer urothelial cells. Our research has also confirmed that the hAM preparations have no harmful effects on normal urothelial cells. In conclusion, we have shown that hAM preparations have multitargeted anticancer effect, which further supports the idea of a possible clinical application of hAM homogenate and extract as additional anti-cancer agents in multi-target intravesical therapy after transurethral resection of bladder tumors.
Secondary keywords: humana amnijska membrana;normalne in rakave urotelijske celice;protirakavo delovanje;homogenat;doktorske disertacije;Molekularna biologija;Bolezni sečil;Onkologija;Univerzitetna in visokošolska dela;
Type (COBISS): Doctoral dissertation
Study programme: 0
Embargo end date (OpenAIRE): 1970-01-01
Thesis comment: Univ. v Ljubljani, Biotehniška fak.
Pages: 1 spletni vir (1 datoteka PDF (XIII, 155 str., [1] str. pril.))
ID: 16696932